ABBVIE OPERATIONS SINGAPORE PTE LTD

Business Nature: Manufacturing Plant

Corporate Profile:

AbbVie Operations Singapore Pte Ltd is a significant manufacturing hub for AbbVie, a global research-based biopharmaceutical company. The Singapore facility focuses on the production of high-quality active pharmaceutical ingredients (APIs) and finished drug products to support the company’s global supply chain. By leveraging advanced manufacturing technologies and adhering to stringent international quality and safety standards, the Singapore site plays a critical role in delivering innovative medicines to patients worldwide. The company is committed to operational excellence, sustainability, and contributing to the development of the healthcare and biopharmaceutical ecosystem in Singapore.

ABBVIE OPERATIONS SINGAPORE PTE LTD primarily manufactures active pharmaceutical ingredients (APIs) and finished drug products for global distribution. The products associated with its manufacturing operations often include key medicines from AbbVie's portfolio, such as:

Humira (adalimumab)

Skyrizi (risankizumab)

Rinvoq (upadacitinib)

Imbruvica (ibrutinib)

Venclexta / Venclyxto (venetoclax)

The facility supports AbbVie's global supply chain across various therapeutic areas including immunology and oncology.